Cdex, Inc. (fka CDEX)

[Viking65]

News for 'CEXI' - (CDEX Showcases the ValiMed(TM) G4 System at the 46th ASHP Conference VG4 System Features Multi-Compound Measurement and Validation)


TUCSON, AZ, Dec 06, 2011 (MARKETWIRE via COMTEX) -- CDEX Inc. (OTCBB: CEXI), a
leading developer of chemical detection products using patented technologies for
use in healthcare, safety and security markets, today demonstrated its recently
launched ValiMed(TM) G4 multi-component medication and narcotic detection system
at the 46th Annual Midyear ASHP Clinical Meeting and Exhibition. The ASHP
conference is being held at the New Orleans Ernest N. Morial Convention Center
in New Orleans, Louisiana, December 4-8, 2011. The ValiMed(TM) G4 will be
showcased at booth 247 at the conference.

The ValiMed G4 drug validation system helps healthcare providers ensure patient
safety and control costs by reducing medication errors. The patented detection
process identifies drug strengths and volume-by-weight in real-time, validating
proper dose, diluents and concentration of high-risk compounded medications and
treatment solutions. The VG4 device will help healthcare facilities comply with
Joint Commission compliance requirements and USP 797 guidelines for compounding
sterile preparations (CSPs), and will integrate with electronic medical record
(EMR) platforms.

"With the recent launch and commercial production of our ValiMed(TM) G4 system,
we are excited to showcase the system at the ASHP Midyear conference, where a
national and international audience of industry professionals will witness the
power of our technology. We are the first to commercialize an affordable
advanced measuring system, with multi-component capabilities that will enhance
and improve the quality of care that pharmacies and clinical professionals
provide. The conference should provide an optimum platform for our ValiMed G4 to
gain market penetration and build industry buzz for our system. We expect to
deliver several units over the next six months as the market interest continues
to spread for the VG4," stated Jeff Brumfield, chairman and chief executive
officer of CDEX.

CDEX's VG4 significantly raises the bar for patient medication safety and
pharmaceutical drug loss prevention. The ValiMed G4 provides cutting edge
features and benefits over existing systems available in the market. In addition
to validating high-risk medications before leaving the clinical or pharmacy
environment, the ValiMed G4 will also monitor and discourage the diversion of
controlled substances by validating the returned or unused narcotics from
patient treatment areas or surgery suites. Other applications for the ValiMed G4
system include counterfeit medication monitoring, regulatory compliance and
training of clinical and pharmacy personnel.

The American Society of Health-System Pharmacists (ASHP) Midyear Clinical
Meeting and Exhibition is the largest gathering of pharmacists in the world.
With its focus on improving patient care, the conference is attended by more
than 20,000 pharmacy professionals from 86 countries. For over four decades, the
ASHP Midyear Clinical Meeting has provided health-system pharmacy practitioners
with a venue for updating their knowledge, networking with colleagues, enhancing
their skills, and learning about the latest products and technologies available
in the market. For more information about the event please visit:
http://www.ashp.org/Midyear2011.